Sinco Pharmaceutical Holdings (HKSE:06833) Total Inventories : HK$376 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Sinco Pharmaceutical Holdings Total Inventories?

Sinco Pharmaceutical Holdings's total inventories for the quarter that ended in Dec. 2024 was HK$376 Mil. Sinco Pharmaceutical Holdings's average total inventories from the quarter that ended in Jun. 2024 to the quarter that ended in Dec. 2024 was HK$212 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Sinco Pharmaceutical Holdings's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was HK$-0.25.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Sinco Pharmaceutical Holdings's Days Inventory for the six months ended in Dec. 2024 was 31.02.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sinco Pharmaceutical Holdings's Inventory Turnover for the quarter that ended in Dec. 2024 was 5.88.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sinco Pharmaceutical Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.15.

Sinco Pharmaceutical Holdings Total Inventories Historical Data

The historical data trend for Sinco Pharmaceutical Holdings's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinco Pharmaceutical Holdings Total Inventories Chart

Sinco Pharmaceutical Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Inventories

Get a 7-Day Free Trial

287.54

75.02

98.44

118.16

376.18

Sinco Pharmaceutical Holdings Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Inventories	Get a 7-Day Free Trial															98.44	10.37	118.16	47.59	376.18

Sinco Pharmaceutical Holdings Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Sinco Pharmaceutical Holdings (HKSE:06833) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Sinco Pharmaceutical Holdings's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

	Net-Net Working Capital Per Share (Q: Dec. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(329.185	+	0.75 * 544.145	+	0.5 * 376.18	-	1428.058
-	0	-	0)	/	2032.891
=	-0.25

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sinco Pharmaceutical Holdings's Days Inventory for the six months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	211.8845	/	1246.764	*	365 / 2
	=	31.02

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sinco Pharmaceutical Holdings's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	1246.764	/	211.8845
	=	5.88

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sinco Pharmaceutical Holdings's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	211.8845	/	1382.069
	=	0.15

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Sinco Pharmaceutical Holdings Total Inventories Related Terms

Thank you for viewing the detailed overview of Sinco Pharmaceutical Holdings's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinco Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinco Pharmaceutical Holdings Ltd (HKSE:06833) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1700, North Section of Tianfu Avenue, E5-1805, Global Centre, High-Tech Zone, Chengdu, Sichuan Province, Chengdu, CHN

Website

https://www.sinco-pharm.com

Sinco Pharmaceutical Holdings Ltd is an investment holding company that deals in marketing, promotion, and channel management of improved human plasma-based pharmaceuticals, antibiotics, and other pharmaceuticals. The company operates in three business segments, namely biologics, medical aesthetic products, and biopharmaceutical cold chain and supply chain services. The biologics business provides marketing, promotion, and channel management services, while the medical aesthetic products business focuses on research and development, production, and sales of aesthetic medicine in China. The biopharmaceutical cold chain and supply chain services concentrate on the construction of cold chain facilities for biopharmaceutical products and establishing the supply chain service platform.

Executives

Huang Zhijian	2305 Beneficiary of a trust
Fullwealth Holdings Limited	2201 Interest of corporation controlled by you
Risun Investments Limited	2101 Beneficial owner
Wickhams Cay Trust Company Limited	2301 Trustee
Huang Xiangbin	2307 Founder of a discretionary trust who can infl

Sinco Pharmaceutical Holdings Headlines

No Headlines